FIELD: organic chemistry, chemical technology, pharmacy. SUBSTANCE: invention describes novel derivatives of condensed 1,2,4-thiadiazine of the general formula (I) given in the description where B means one of bonds in double bond between atoms 2 and 3 of ring of the formula (I); D means -S(=O)2-; R1 means hydrogen atom; R4 means hydrogen atom; or R4 in common with R5 means one of bonds in double bond between atoms 2 and 3 of the formula (I); or R1 in common with R4 means one of bonds in double bond between atoms 3 and 4 of the formula (I); R2 means hydrogen atom, C1-6-alkyl, C3-6-cycloalkyl, C2-6-alkenyl; R3 means R8, aryl substituted with C1-6-alkyl where R8 means hydrogen atom, C3-6-cycloalkyl or (C3-6-cycloalkyl)-C1-6-alkyl, unbranched or branched C1-18-alkyl, with optionally mono- or polysubstituted hydroxy-group, C3-6-cycloalkyl, aryl, carboxy-group; A in common with 5 and 6 carbon atoms of the formula (I) means 5-membered heterocyclic system containing one or two nitrogen atoms or one sulfur atom being heterocyclic systems are optionally mono- or poly-substituted with halogen atom under condition of excluding the following compounds: 3-aminoimidazo-[4,5-e] -1,2,4-thiadiazine 1,1-dioxide and 3-(benzoylamino)-imidazo-[4,5-e] -1,2,4-thiadiazine 1,1-dioxide or its salt with pharmaceutically acceptable acid or base. New compounds are used as agents opening KATF-regulated potassium channels. Also, invention describes pharmaceutical composition eliciting effect on KATF-regulated potassium channels and method of effect on KATF-regulated channels. EFFECT: improved method of synthesis, valuable medicinal properties of compounds. 18 cl, 23 ex
Title |
Year |
Author |
Number |
CONDENSED DERIVATIVE OF 1,2,4-THIADIAZINE, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING MEDICINE |
1998 |
- Nil'Sen Flemming Ehl'Medlunn
- Khansen Jokhn Bondo
- Khansen Khol'Ger Klaus
- Tagmose Tina Meller
- Mogensen Jokhn Patrik
|
RU2215004C2 |
DERIVATIVES OF PYRIDO-1,2,4-THIADIAZINE OR PYRIDO-1,4-THIAZINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF MANIFESTATION OF ACTIVITY INHIBITING INSULIN SECRETION |
1997 |
- Pirott Bernar
- Lebren Filip
- De Tjull'O Paskal'
- Somer Fabian
- Delarzh Zhak Ehli
- Khansen Khol'Ger Klaus
- Nil'Sen Flemming Ehl'Melunn
- Khansen Jokhn Bondo
|
RU2193564C2 |
DERIVATIVES OF [1,2,4]-TRIAZOLO-[4,3-A]-QUINOXALINONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF AMPA- -RECEPTORS |
1995 |
- Nel'Sen Flemming Ehl'Melund
|
RU2149162C1 |
COMPOUNDS AND PHARMACEUTICAL COMPOSITION POSSESSING PROPERTY FOR GROWTH HORMONE RELEASING, METHOD FOR STIMULATION OF SECRETION OF GROWTH HORMONE FROM MAMMAL HYPOPHYSIS |
1999 |
- Peshke Bernd
- Rikhter Shtefan Lutts
- Khansen Tomas Kruse
- Ankersen Mikaehl'
|
RU2298547C2 |
DERIVATIVES OF PIPERIDINE CARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF, METHOD FOR STIMULATION OF GROWTH HORMONE SECRETION |
1999 |
- Khansen Tomas Kruse
- Ankersen Mikaehl'
|
RU2243215C2 |
COMPOUNDS AND THEIR USING FOR DECREASING HORMONE-SENSITIVE LIPASE ACTIVITY |
2002 |
- Ehbdrup Seren
- Kornelis De Jong Jokhannes
- Jakobsen Paul'
- Khansen Khol'Ger Klaus
- Vedse Per
|
RU2317981C2 |
STEROIDS, METHOD OF REGULATION OF MEIOSIS |
1996 |
- Frederik Khristian Grenvall'
- Peter Forup
- Ehrling Guddal'
|
RU2182909C2 |
2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND METHODS OF SYNTHESIS |
1993 |
- Kristian Foged
- Rol'F Kholveg
- Ehrik Bardrum Nil'Sen
|
RU2114839C1 |
DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS |
2013 |
- Zhang Yingjun
- Ren Qingyun
- Liu Xinchang
- Goldmann Siegfried
|
RU2655914C9 |
METHOD FOR IMPROVEMENT OF STABILITY OF SWEET TASTE INTENSIFIERS AND COMPOSITION CONTAINING STABILISED SWEET TASTE INTENSIFIER |
2011 |
- Tachdzhian Ketrin
- Karanevski Donald S.
- Tan Sjao-Tsin
- Lju Khankhuej
|
RU2576451C2 |